AntineoplasticsLack of efficacy and off label use: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2023年 / 1938卷 / 1期

关键词：

D O I：

10.1007/s40278-023-30285-1

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：144 / 144

相关论文

共 50 条

[31] AnidulafunginLack of efficacy and off label use: case report
Reactions Weekly, 2025, 2044 (1) : 34 - 34
[32] AntineoplasticsLack of efficacy and various toxicities following off-label use: 26 case reports
Reactions Weekly, 2023, 1950 (1) : 47 - 47
[33] Avapritinib/ImatinibLack of efficacy and off label use: case report
Reactions Weekly, 2024, 2037 (1) : 71 - 71
[34] Multiple drugsLack of efficacy and off label use: case report
Reactions Weekly, 2021, 1860 (1) : 249 - 249
[35] Multiple drugsLack of efficacy and off label use: case report
Reactions Weekly, 2022, 1916 (1) : 296 - 296
[36] Multiple drugsLack of efficacy and off label use: case report
Reactions Weekly, 2021, 1845 (1) : 262 - 262
[37] CurcuminLack of efficacy following off label use: case report
Reactions Weekly, 2022, 1930 (1) : 212 - 212
[38] RomidepsinLack of efficacy following off label use: case report
Reactions Weekly, 2022, 1922 (1) : 524 - 524
[39] Colchicine/mepolizumabLack of efficacy and off label use: case report
Reactions Weekly, 2023, 1957 (1) : 168 - 168
[40] Ketamine/naltrexoneLack of efficacy and off label use: case report
Reactions Weekly, 2023, 1948 (1) : 251 - 251

← 1 2 3 4 5 →